Caisse Des Depots ET Consignations Buys New Holdings in Cardinal Health, Inc. (NYSE:CAH)

Caisse Des Depots ET Consignations bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 37,096 shares of the company’s stock, valued at approximately $4,387,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CAH. Rothschild Investment LLC lifted its holdings in shares of Cardinal Health by 10.1% during the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after acquiring an additional 79 shares in the last quarter. Private Trust Co. NA lifted its position in Cardinal Health by 11.0% during the 4th quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after acquiring an additional 92 shares in the last quarter. Checchi Capital Advisers LLC boosted its holdings in Cardinal Health by 2.7% in the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock worth $411,000 after acquiring an additional 93 shares during the period. TIAA Trust National Association raised its stake in shares of Cardinal Health by 4.5% during the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company’s stock valued at $258,000 after purchasing an additional 94 shares during the period. Finally, MWA Asset Management boosted its stake in shares of Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after purchasing an additional 95 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of CAH stock opened at $133.91 on Thursday. The stock’s fifty day simple moving average is $127.96 and its 200 day simple moving average is $120.48. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $134.86. The firm has a market cap of $32.35 billion, a price-to-earnings ratio of 24.98, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.51%. Cardinal Health’s dividend payout ratio (DPR) is currently 37.69%.

Analyst Ratings Changes

CAH has been the subject of several recent analyst reports. JPMorgan Chase & Co. raised their target price on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Mizuho initiated coverage on Cardinal Health in a research report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price target on the stock. Morgan Stanley increased their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an “overweight” rating in a report on Friday, January 31st. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, Wells Fargo & Company raised their price target on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. According to data from MarketBeat.com, Cardinal Health currently has an average rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.